IOVA Stock: Price, Earnings History and SEC Filings
Iovance Biotherapeutics, Inc. (IOVA) last traded at $8.48, down 11.30% on the latest session and down 42.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.11 against an analyst estimate of $-0.17, a beat of 35.3%.
$8.48 -11.30%
1 month-42.78%
52-week high$15.37
52-week low$1.76
Volume31.20M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
IOVA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.11 | $-0.17 | +35.29% |
| Mar 2026 | May 7, 2026 | $-0.19 | $-0.19 | +0.00% |
| Dec 2025 | Feb 24, 2026 | $-0.18 | $-0.22 | +18.18% |
| Sep 2025 | Nov 6, 2025 | $-0.25 | $-0.29 | +13.79% |
IOVA beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for IOVA
SEC filing data is not available right now. You can search for IOVA on SEC EDGAR.
IOVA news
- Iovance Sinks Another 11% as Baird Cuts Target to $9 After Lung Cancer DataOct 30, 2026 · tikr.com
- Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer TwistOct 30, 2026 · finance.yahoo.com
- Iovance Biotherapeutics (IOVA) Posts 59.1% Response In Lifileucel Lung Cancer StudyOct 30, 2026 · finance.yahoo.com
- GILD Beats Q3 Earnings on HIV Strength & Trodelvy Sales GrowthOct 30, 2026 · finance.yahoo.com
- INSM Q3 Earnings Miss, Stock Soars on Sales Beat & Raised GuidanceOct 30, 2026 · finance.yahoo.com
- Is 50% Crash Risk For Iovance Stock Real?Oct 30, 2026 · trefis.com
- SLS, IOVA, IBRX Slump In October As Biotech Stocks Hold Steady: Virginia Pension Fund Raised Stakes In All 3Oct 30, 2026 · stocktwits.com
- Illumina (ILMN) Q3 Earnings Beat EstimatesOct 29, 2026 · finance.yahoo.com
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. (IOVA) is a US-listed public company on Nasdaq.